A Novel Azaindolizinone Derivative ZSET1446 (Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3 H)-one) Improves Methamphetamine-Induced Impairment of Recognition Memory in Mice by Activating Extracellular Signal-Regulated Kinase 1/2
Authors:
- Kazuhiro TakumaKTKazuhiro Takuma
- Hiroyuki MizoguchiHMHiroyuki Mizoguchi
- Taku NagaiTNTaku Nagai
- Kiyofumi YamadaKYKiyofumi Yamada
- 1 February 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 320 (2) , 819-827
Abstract
The effect of ZSET1446 (spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) on cognitive impairment in mice, previously treated with methamphetamine (METH) at a dose of 1 mg/kg for 7 days, was investigated. ZSET1446 showed a significant ameliorating effect on METH-induced impairment of recognition memory, although it had no effect on exploratory behavior. ZSET1446 (1 μg/kg) recovered the defect of the novelty-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) in the prefrontal cortex (PFC) of METH-treated mice. The compound increased phosphorylated ERK1/2 levels in the hippocampus but not PFC of naive mice without affecting the total ERK1/2 levels. The ameliorating effect of ZSET1446 on recognition memory in METH-treated mice was negated by pretreatment with a mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor, SL327 (α-[amino-(4-aminophenylthio)methylene]-2-(trifluoromethyl)phenylacetonitrile). Furthermore, the dopamine D1 receptor antagonist, SCH23390 [R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine], and N-methyl-d-aspartate (NMDA) receptor antagonist, MK-801 [5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate)], blocked the ameliorating effect of ZSET1446 on METH-induced memory impairment, whereas the D2 receptor antagonist, raclopride, had no effect. These results suggest that the ameliorative effect of ZSET1446 on METH-induced memory impairment is associated with indirect activation of ERK1/2 following stimulation with dopamine D1 and NMDA receptors of the PFC. ZSET1446 would be a potential candidate for further preclinical study aimed at the treatment of cognitive deficits in Alzheimer9s disease and schizophrenia, as well as METH psychosis.Keywords
This publication has 34 references indexed in Scilit:
- Ventromedial Prefrontal Cortex Is Obligatory for Consolidation and Reconsolidation of Object Recognition MemoryCerebral Cortex, 2005
- Essential role of D1 but not D2 receptors in methamphetamine‐induced impairment of long‐term potentiation in hippocampal–prefrontal cortex pathwayEuropean Journal of Neuroscience, 2005
- Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in ratsBehavioural Brain Research, 2005
- Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptorsProceedings of the National Academy of Sciences, 2004
- Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897–NR1Journal of Neurochemistry, 2003
- Methamphetamine Dependence Is Associated With Neurocognitive Impairment in the Initial Phases of AbstinenceThe Journal of Neuropsychiatry and Clinical Neurosciences, 2003
- Diversity of G Protein-Coupled Receptor Signaling Pathways to ERK/MAP KinaseNeurosignals, 2002
- Essential Role of D1 But Not D2 Receptors in the NMDA Receptor-Dependent Long-Term Potentiation at Hippocampal-Prefrontal Cortex SynapsesIn VivoJournal of Neuroscience, 2000
- Primate analogue of the Wisconsin card sorting test: Effects of excitotoxic lesions of the prefrontal cortex in the marmoset.Behavioral Neuroscience, 1996
- Dissociation in prefrontal cortex of affective and attentional shiftsNature, 1996